Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis-Reference-Cited by-同舟云学术

Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis

Published:2019-08-22 Issue:1 Volume:21 Page:
ISSN:1532-429X
Container-title:Journal of Cardiovascular Magnetic Resonance
language:en
Short-container-title:J Cardiovasc Magn Reson

Author:

Arenja Nisha,Andre Florian,Riffel Johannes H.,Siepen Fabian aus dem,Hegenbart Ute,Schönland Stefan,Kristen Arnt V.,Katus Hugo A.,Buss Sebastian J.

Funder

Mach Gaensslen Stiftung

B. Braun-Stiftung

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://link.springer.com/content/pdf/10.1186/s12968-019-0564-1.pdf

Reference44 articles.

1. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am. 1999;13(6):1211–33 ix.

2. Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, Quellard N, Lacombe C, Goujon JM, Lavergne D, et al. Al amyloidosis. Orphanet J Rare Dis. 2012;7:54.

3. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004;140(2):85–93.

4. Cohen AD, Comenzo RL. Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy. Hematology Am Soc Hematol Educ Program. 2010;2010:287–94.

5. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583–96.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric analysis of light chain amyloidosis from 2005 to 2024: research trends and hot spots;Frontiers in Medicine;2024-07-30

2. Prognostic Value of Serum Galectin-3 for Survival in Patients with Cardiac Light-Chain Amyloidosis;Journal of Cardiovascular Development and Disease;2024-06-29

3. Prognostic value of cardiac magnetic resonance imaging feature tracking technology in patients with light chain amyloidosis;Clinical Radiology;2024-02

4. Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies;World Journal of Cardiology;2023-10-26

5. Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis;Reviews in Cardiovascular Medicine;2023-10-16